| Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, today announced that it has secured £3.5m in new equity financing, including £2.5m from lead investor |
Here’s... yadoT hsilluB erA sredloH PRXEight-hour... niw yaD gnixoB pu skcab iaD thMicrosoft... omed noitcerroc rorre mutnauq2... woN thgiR yuB ot snekoT ekatS-Polka... ?sreggerp yas ot stod akloPSEC... sotpA htiw srentrap tfosorciMSEC... emehcS noitomorP otpyrC nI nokSandeep... eganortap no snruter fo tra s’Australian... yduts lamina ni htworg surivanNexo... noitpO nraE weN htiW gnireff